Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,524.00    72.00 (1.62%)
Bid:
4,520.00
Ask:
4,534.00
Spread: 14.00 (0.31%)
Market Cap: £2.11b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Directorship Changes

12 Dec 2023 07:00

RNS Number : 3963W
Morgan Sindall Group PLC
12 December 2023
 

 

12 December 2023

 

 

Morgan Sindall Group plc

 

Directorship changes

 

Morgan Sindall Group plc (the 'Company') today announces that Steve Crummett, Finance Director, has informed the Board of his intention to retire from the Company on 31 December 2024.

 

The Board also announces that following a search process, Kelly Gangotra, currently Chief Financial Officer, Healthcare Sector at Halma plc and previously Chief Financial Officer of Skanska UK, has been selected to succeed Steve as Finance Director.

 

Kelly will be appointed as Finance Director and become a member of the Board on a date to be agreed, expected to be around the third quarter of 2024, when Steve will step down from both roles. This will then allow for a period of transition until Steve retires from the Company at the end of the year.

 

John Morgan, Group Chief Executive Officer said: "I'd like to thank Steve for his exceptional contribution to the Board over the last ten years. Steve has seen the business through a period of significant growth and has helped shape our strategic direction and ensured that the financial stewardship of the business over the last 10 years has supported the Group's long term growth.

 

"I am delighted that Kelly will join the Group in 2024 and I look forward to working with her over the years ahead. She has an excellent track record as a CFO working in a decentralised business, is highly experienced in the construction and property industry and her valuable and significant skills and insight will support me and the Board as the Group continues to develop and grow." 

 

ENDS

A statement concerning particulars of remuneration payments in accordance with section 430(2B) of the Companies Act 2006 will be published in due course.

 

Note to Editors

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

Kelly Gangotra

 

Kelly has extensive financial and commercial leadership experience across the construction and property sectors and has served as the CFO of the Healthcare division of Halma plc since August 2022. Prior to Halma, Kelly spent a decade with Skanska Plc in the UK where she was firstly Finance Director from 2012 to 2015 and then CFO and Executive Vice President between 2015 and 2022. She has also held senior finance roles at Alliance Medical and Biffa Waste Services.

 

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Kelly Gangotra.

 

 

 

Morgan Sindall Group

Michael Findlay (Chair)

John Morgan

 

Brunswick

Jonathan Glass

Nina Coad

Tel: 020 7307 9200

 

 

 

Tel: 020 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGAGPUPWGMG
Date   Source Headline
2nd Jun 202511:14 amRNSCompany Secretary Change
8th May 20258:36 amRNSAdditional Listing
7th May 20252:30 pmRNSHolding(s) in Company
1st May 202512:42 pmRNSResult of AGM
1st May 20259:30 amRNSTotal Voting Rights
1st May 20257:00 amRNSTrading Update
22nd Apr 20252:00 pmRNSCompany Secretary Change
22nd Apr 202510:11 amRNSBlock listing Interim Review
22nd Apr 20258:43 amRNSHolding(s) in Company
1st Apr 20259:38 amRNSTotal Voting Rights
27th Mar 20259:53 amRNSDirector/PDMR Shareholding
25th Mar 20251:50 pmRNSAdditional Listing
25th Mar 20257:00 amRNSTrading Update
24th Mar 20254:32 pmRNSHolding(s) in Company
20th Mar 20252:08 pmRNSAnnual Financial Report
14th Mar 202511:14 amRNSDirector/PDMR Shareholding
7th Mar 20251:33 pmRNSDirector/PDMR Shareholding
7th Mar 20251:26 pmRNSDirector/PDMR Shareholding
6th Mar 20254:42 pmRNSDirector/PDMR Shareholding
6th Mar 20254:38 pmRNSDirector/PDMR Shareholding
5th Mar 20258:56 amRNSDirector/PDMR Shareholding
3rd Mar 20259:41 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSResults for the Full Year Ended 31 December 2024
19th Feb 20253:20 pmRNSHolding(s) in Company
11th Feb 202512:00 pmRNSAppointment of Joint Corporate Broker
7th Feb 20252:37 pmRNSHolding(s) in Company
3rd Feb 202510:10 amRNSTotal Voting Rights
16th Jan 20257:07 amRNSDirector Declaration
16th Jan 20257:00 amRNSNotice of Full Year Results
15th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202511:56 amRNSTotal Voting Rights
20th Dec 20243:54 pmRNSDirector/PDMR Shareholding
2nd Dec 202410:02 amRNSTotal Voting Rights
6th Nov 20241:18 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20244:17 pmRNSDirector/PDMR Shareholding
28th Oct 20249:24 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update and Outlook for 2024
21st Oct 20249:27 amRNSBlock listing Interim Review
15th Oct 202412:22 pmRNSAdditional Listing
1st Oct 202412:09 pmRNSTotal Voting Rights
27th Sep 20242:46 pmRNSDirector/PDMR Shareholding
10th Sep 202411:44 amRNSAdditional Listing
2nd Sep 202410:45 amRNSTotal Voting Rights
30th Aug 202410:35 amRNSHolding(s) in Company
30th Aug 20249:29 amRNSDirector/PDMR Shareholding
23rd Aug 20242:48 pmRNSDirector/PDMR Shareholding
12th Aug 20249:52 amRNSHolding(s) in Company
9th Aug 20244:50 pmRNSHolding(s) in Company
8th Aug 20247:00 amRNSRESULTS FOR THE HALF YEAR (HY) ENDED 30 JUNE 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.